Patents by Inventor Vincenzo Savica

Vincenzo Savica has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140356297
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Application
    Filed: August 18, 2014
    Publication date: December 4, 2014
    Inventor: Vincenzo Savica
  • Patent number: 8518379
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: August 27, 2013
    Assignee: CM&D Pharma Limited
    Inventor: Vincenzo Savica
  • Publication number: 20110002858
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Application
    Filed: September 16, 2010
    Publication date: January 6, 2011
    Inventor: Vincenzo SAVICA
  • Publication number: 20100316578
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Application
    Filed: August 23, 2010
    Publication date: December 16, 2010
    Inventor: Vincenzo SAVICA
  • Patent number: 7815898
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: October 19, 2010
    Assignee: CM&D Pharma Limited
    Inventor: Vincenzo Savica
  • Publication number: 20090306013
    Abstract: The present invention relates to an alimentary component comprising a physiologically acceptable phosphorus binding agent, in particular polyallylamine hydrochloride, polyallylamine carbonate, lanthanum carbonate, aluminium hydroxide, magnesium acetate, magnesium carbonate, calcium carbonate, calcium acetate, calcium citrate, calcium alginate, styrene divinyl-benzene ionic exchange resin, stabilized polynuclear iron hydroxide, calcium acetate plus magnesium carbonate and chitosan. Said component is useful in the nutrition of subjects in need of a low phosphorus level diet.
    Type: Application
    Filed: April 3, 2007
    Publication date: December 10, 2009
    Inventor: Vincenzo Savica
  • Publication number: 20080125394
    Abstract: The present invention provides medicaments useful for reducing phosphorus serum level, especially in those subjects affected from hyperphosphatemia. More specifically, the present invention relates to pharmaceutical compositions to be administered by oral route in fasting periods, in order to absorb phosphorus compounds from fluids of the enteric tract, especially from saliva.
    Type: Application
    Filed: November 29, 2005
    Publication date: May 29, 2008
    Inventor: Vincenzo Savica